Nasdaq Cinc News Today

Investing in small-cap stocks is usually a very risky business, but they could offer quick and hefty returns. Also, the cheap share price of small-cap

The IPO market has been slow this year as investors’ risk appetite for new issues hit a record low. As of last month, there were just 161 initial publ

WALTHAM, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on...

WALTHAM, Mass., Aug. 11, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on...

Brokerages expect CinCor Pharma, Inc. (NASDAQ:CINC – Get Rating) to report ($0.50) earnings per share for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates for CinCor Pharma’s earnings. The highest EPS estimate is ($0.43) and the lowest is ($0.55). The company is expected to report its next quarterly earnings report […]

Brokerages expect CinCor Pharma, Inc. (NASDAQ:CINC – Get Rating) to announce earnings per share of ($0.50) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for CinCor Pharma’s earnings, with the highest EPS estimate coming in at ($0.44) and the lowest estimate coming in at ($0.59). The business is scheduled to […]

CinCor Pharma (NASDAQ:CINC – Get Rating) posted its earnings results on Tuesday. The company reported ($15.71) EPS for the quarter, missing the Zacks’ consensus estimate of ($1.56) by ($14.15), MarketWatch Earnings reports. NASDAQ CINC traded up $0.09 on Thursday, hitting $15.39. 344 shares of the company traded hands, compared to its average volume of 247,779. […]

CinCor Pharma Inc (NASDAQ:CINC – Get Rating) shares gapped down before the market opened on Wednesday following a dissappointing earnings announcement. The stock had previously closed at $15.77, but opened at $15.01. CinCor Pharma shares last traded at $14.98, with a volume of 1,078 shares traded. The company reported ($15.71) EPS for the quarter, missing […]

BOSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing...